PROCEEDINGS OF THE AUSTRALIAN SOCIETY FOR MEDICAL RESEARCH

1. The pituitary‐adrenal axis in the guinea‐pig: studies on ACTH secretion. M.J. Martin, A.E. McClelland and J.W. Funder 2. A sensitive radioimmunoassay for human (β h EP) and camel (β c CEP) β‐Endorphin. Judith Clements and J.W. Funder 3. Effect of leu‐enkephalin on serum Cortisol levels in man. G.A. Smythe, R. McGinley, D.J. Chisholm and L. Lazarus 4. Binding of 17 a OH progesterone (17 a OHP) to intracellular sites within bovine liver. J.W. Barlow and J. Funder 5. Studies on the modes of action of tamoxifen, a potent oestrogen antagonist. M.S. Foo and R.L. Sutherland 6. Angiotensinogen in liver cells: localization by immunocytochemistry. Brian J. Morris, Harriet S. Iwamoto and Ian A. Reid 7. Binding of human growth hormone (hGH) to growth hormone and prolactin receptors: effect of concanavalin A. A.C. Herington and Denise Elson 8. Parathyroid hormone and cyclic AMP metabolism in chick renal tubules. N.H. Hunt, J.K. Dawborn and T.J. Martin 9. Further studies on the factor VIII of a patient with a variant form of von Willebrand's disease. Margaret A. Howard, Lyne Hendrix and B.G. Firkin 10. Human factor VIII binding to platelets. J. Koutts and T.S. Zimmerman 11. Platelet aggregation and secretion: effects of low concentrations of heparin . N.G. Ardlie, V. Frewin, C. Boatwright and G. Schoefl 12. Basal and prostaglandin stimulated cyclic AMP levels of human platelets in normal and hypercholesterolaemic subjects. J.A. Jakubowski and N.G. Ardlie 13. Studies on the function of platelet surface antigens. J. Connellan, I. Smith, B. Barlow and P.A. Castaldi 14. Identification of platelet membrane antigens. S.L Pfueller and P. Hosseinzadeh 15. Effect of storage temperature on platelet aggregation, release and shape. S.E. Watts, J.V. Lloyd and R.J. Kimber 16. A defect in homeostasis in chronic idiopathic thrombocytopenic purpura. R.J. Trent, R.L. Clancy and V. Danis 17. Function of serum in leucocyte adherence inhibition. A.E. Maluish and W.J. Halliday 18. 125 I labelling of macrophage plasma membrane with chloramine ‐T. W.A. Davies 19. Suppressor cells in chronic lymphatic leukaemia (CLL). J. Wotherspoon, P. Hodson, P. Hersey and F.W. Gunz 20. Microassay of blood histamine release in diagnosis and treatment of allergy . K.M. Taylor, S. Krilis, B.A. Baldo and A. Basten 21. Erythrocyte autoantibody production diminished by autoantibody‐induced suppressor cells. N.F. Gare and K.O. Cox 22. Exacerbation of erythrocyte autoantibody production by splenectomy . K.O. Cox and J.J. Finlay‐Jones 23. Prednisolone effects on monocyte chemotaxis; normal subjects and patients on long‐term steroid therapy A.R. Tanner, J.W. Halliday and L.W. Powell 24. The interaction of human IgE with lymphoid cells . H. Zola 25. Stimulation of aldosterone production from zona glomerulosa cells in vitro by normal human serum . F.A.O. Mendelsohn and C. Kachel 26. Dopamine receptors in the kidney . William R. Adam and Janine Danks 27. Salt balance, haemorrhage and activation of renin in the rat kidney A. Gillies, L. Thompson and T. Morgan 28. Renal tubular magnesium handling and PTH . S. Carney, N. Wong, G. Quamme and J. Dirks 29. Studies on the mechanism of the potentiation of human vascular smooth muscle contraction by angiotensin. R.F.W. Moulds 30. Augmented circulating bradykinin following angiotensin converting enzyme (ACE) inhibition. P.G. Matthews and C.I. Johnston 31. Increased noradrenaline (NA) concentration in cerebellum and spinal cord of stroke‐prone spontaneously hypertensive rats. P.R.C. Howe, J.C. Provis, M.J. West and J.P. Chalmers 32. Activation of the sympathoadrenal system during head‐up tilt . M.J. Morris, B.P. McGrath, J. A. Millar and A.J. Barnett 33. Calcitonin production and action in a human cancer cell line. D.M. Findlay, M. de Luise, V.P. Michelangeli and T.J. Martin 34. Metabolic properties of osteogenic sarcoma cells . N.C. Partridge, M.J. Doyle, B.E. Kemp and V.P. Michelangeli 35. Western Australian Blood donors who lack immunoglobulin A. S. Leivers, F. Christiansen, M. French and M.G. Davey 36. Biochemistry of the cell cycle: Cell fractionation by centrifugal elutriation. A.A. Piper, C.A. McCaffery, B.K. Milthorpe, R.M. Fox and M.H.N. Tattersall 37. Proliferative defect of marrow cells in experimental aplastic anaemia (EAA) K.J. Trainor, A.A. Morley and R.S. Seshadri 38. Pyrimidine metabolism in human adenosine deaminase deficient lymphoblasts. N.F. Parker, I. Jack and M.B. van der Weyden 39. Thymidine phosphorylase deficiency in cultured human T leukaemic lymphocytes: determinant of sensitivity to pyrimidine antimetabolites. S.K. Piddington, A.A. Piper, M.H.N. Tattersall and R.M. Fox 40. ONA repair studies on human peripheral lymphocytes. D.R. Turner, A.A. Morley, J.R. Sorrell and R.S. Seshadri 41. Partial characterization of hepatitis B surface antigen subtypes with a view to development of a synthetic vaccine D.L. Peterson, I.M. Roberts and G.N. Vyas 42. Studies on HBeAg, anti‐HBe and DNA polymerase in patients with and without HBs antigenemia . M.M. Newkirk, J.W. Halliday, L.W. Powell and J. Harper 43. Suppression of lymphocyte transformation by sera from patients with alcoholic liver disease. I.S. Rose, G.P. Young, F.J. Dudley and M.B. van der Weyden 44. The kinetics of hepatic antipyrine metabolism and the effect of smoking. R.A. Bradbear , W.G.E. Cooksley, L. Bass, G. Yates, E.A. McDonald and L.W. Powell 45. Metabolic activation of paracetamol. Q.J. Chensee, J. Mohandas, S. Mohammed, I. Calder, K. Healey and G.G. Duggin 46. Hepatic iron metabolism in the rat. R.G. Batey, J.P. Milsom and S. Sherlock 47. Development and application of an immunoassay for chenodeoxycholic acid by immunization with unconjugated bile acid. M. Cain, D. Souphandavong and M. Mackinnon 48. Reassessment of the cholesterol saturation of gallbladder and hepatic bile from patients with cholesterol or pigment gallstones or without gallstones. M.J. Whiting, V. Jarvinen, R.H.L. Down and J. McK. Watts 49. A switch‐over in arousal during the menstrual cycle. J. Friedman and R.A. Meares 50. Handling of hypertonic sodium chloride by the ovine foetus. S. Potocnik, K.J. Hardy & E.M. Wintour 51. Immunofluorescence localization of prolactin to human foetal membranes. D.L. Healy, J. Batty, H.K. Muller and H.G. Burger 52. Steroid receptor assays in neoplastic tissues . P. Pearce, D. Allen and J.W. Funder 53. The hereditability of serum cholesterol in early childhood. T.J.C. Boulton and P. Poulis 54. Endocrine changes in transcendental meditation. A.J.W. Bevan 55. Prostaglandins, bone resorption and cancer. M. Greaves, D. Atkins, K.J. Ibbotson and T.J. Martin 56. Prostaglandins and 25‐hydroxyvitamin D‐la‐hydroxylase. J.D. Wark, R.G. Larkins, J.A. Eisman and T.J. Martin 57. Intrarenal distribution of salicylate . R.J. Caterson and G.G. Duggin 58. The role of prostaglandins and cyclic AMP in bronchial hyperreactivity. B.R. Creese and M.A. Denborough 59. Exercise, asthma and cyclic AMP (cAMP). P.T.P. Bye, J.J. Marty, S.D. Anderson and C.P. Perry 60. Allergic reactions to aspirin in patients with chronic urticaria. S. Krilis, B.A. Baldo, R.P. Gregson and A. Basten 61. Biochemical and physical studies on muscle membranes. J.S. Sullivan, J.H. Bradbury and M.A. Denborough 62. Influence of thyroid state on metabolism in isolated myocardial cells. L.C. Read and M.N. Berry 63. Collagen and muscle protein synthesis during cardiac hypertrophy in the dog. CM. Bonnin, R.R. Taylor and M.P. Sparrow 64. The excretion of 3 methylhistidine to measure human muscle protein turnover. L.C. Ward and W.G.E. Cooksley 65. Structure, binding specificity and function of C‐reactive protein (CRP). B.A. Baldo, T.C. Fletcher and A. White 66. Phytogeny of the mucous cells in vertebrate gastric mucosa. A.S. Giraud and N.D. Yeomans 67. Role of smooth muscle cells in atherogenesis. G.R. Campbell and J.H. Chamley‐Campbell 68. Arterial endothelial injury and atherogenesis. G.B. Ryan 69. Platelets and atherogenesis. D.G. Penington 70. Lipoproteins‐the molecular basis for epidemiological findings . P.J. Nestel 71. Glucocorticoid receptors and responses of lymphoid cells. A.W. Harris 72. The hormonal regulation of sex steroid hormone receptor levels in normal and neoplastic tissues. R.L. Sutherland 73. A review of the role of hormone receptors in clinical practice. R.L. Woods 74. Autonomic effects on cardiac electrophysiological parameters. W.F. Heddle, P. Tornos, A. Riggs, H. Rapp and A.M. Tonkin 75. Effect of blood pressure on indices of myocardial ischaemia in the dog . S.P. Lim, M.L. Wahlqvist and C.I. Johnston 76. Affect of ACTH and salt loading on blood pressure in sheep with reduced renal mass. J.A. Whitworth, J.P. Coghlan, D.A. Denton, K.J. Hardy, T.J. Humphrey and B.A. Scroggins 77. Sugar as a source of oxalate in renal stones . A.M. Rofe, R.A.J. Conyers, R. Bais and J.B. Edwards 78. Glomerular C3b receptor–a quantitative approach. L. Schrieber and R. Penny 79. The use of macroelectrodes in distal nephron transepithelial potential difference (PD) measurements. G.G. Allen and L.J. Barratt 80. Congenital dihydrofolate reductase deficiency‐fact or fancy? R.J. Hayman, I. Jack, G. Tauro and M.B. Van der Weyden 81. Folate nutrition affects the distribution of liver folate conjugates. I.C. Cassady, M.J. Healy and P.F. Nixon 82. Dietary vitamin B12 deficiency–effect on hepatic metabolism of vitamin B12 and methyltetrahydrofolate. J. Owens and W.G.E. Cooksley 83. Mechanism of vitamin B12 transport in neonatal rat ileum. J. Brown, N.D. Gallagher and A.W. Morrow 84. Kinetics of serum and tissue ferritins‐effect of carbohydrate content . J.W. Halliday, U. Mack and L.W. Powell 85. Intestinal immunity in bacterial gastroenteritis. J.T. La Brooy, D. Rowley and D.J.C. Shearman 86. Metabolism of low density lipoproteins in rabbits. Y.C. Ha, G.D. Calvert and P.J. Barter 87. Rabbit plasma high density lipoprotein. J.K. Savage, R.A. Yeates, A.M. Mackinnon and G.D. Calvert 88. Cholesterol transport in hyperalphalipoproteinaemia. P.J. Nestel and A. Poyser 89. A study of hypercholesterolaemia in cholestasis. D.R. Williams, A.M. Mackinnon and P.J. Barter 90. Apoprotein levels in patients with myocardial infarction. I.H. Craig, G. Bondjers, G. Fagar, S.‐O. Olofsson, R. Reid, O. Wiklund, L. Wilhelmsen and C. Wilhelmnsson 91. Changes in HDL cholesterol and protein after renal transplantation. E. Savdie, J.C. Gibson, L.A. Simons and J.H. Stewart 92. Biosynthesis and chemistry of progstaglandins. J.E. Pike 93. Physiological aspects of prostaglandins. G.D. Thorburn 94. Prostacyclin: the prostaglandin of physiological importance in the cardiovascular system. G.J. Dusting 95. Prostaglandins in the pathogenesis of disease–malignant hypercalcaemia. T.J. Martin 96. The mechanism of allograft rejection. K.J. Lafferty 98. Drugs from the sea‐fact not fiction. K.M. Taylor